This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Trunkloads of Viruses
COMMENTARY Trunkloads of Viruses Philip E. Pellett Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan, USA Elephant populations are under intense pressure internationally from habitat destruction and poaching for ivory and meat. They also face pressure from infectious agents, including elephant endotheliotropic herpesvirus 1 (EEHV1), which kills ϳ20% of Asian elephants (Elephas maximus) born in zoos and causes disease in the wild. EEHV1 is one of at least six distinct EEHV in a phylogenetic lineage that appears to represent an ancient but newly recognized subfamily (the Deltaherpesvirinae) in the family Herpesviridae. lephant endotheliotropic herpesvirus 1 (EEHV1) causes a rap- the Herpesviridae (the current complete list of approved virus tax- Downloaded from Eidly progressing and usually fatal hemorrhagic disease that ons is available at http://ictvonline.org/). In addition, approxi- occurs in the wild in Asia and affects ϳ20% of Asian elephant mately 200 additional viruses detected using methods such as (Elephas maximus) calves born in zoos in the United States and those described above await formal consideration (V. Lacoste, Europe (1). About 60% of juvenile deaths of captive elephants are personal communication). With very few exceptions, the amino attributed to such infections. Development of control measures acid sequence of a small conserved segment of the viral DNA poly- has been hampered by the lack of systems for culture of the virus in merase (ϳ150 amino acids) is sufficient to not only reliably iden- laboratories. Its genetic study has been restricted to analysis of tify a virus as belonging to the evolutionary lineage represented by blood, trunk wash fluid, and tissue samples collected during nec- the Herpesviridae, but also their subfamily, and in most cases a http://jvi.asm.org/ ropsies. -
Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood
pathogens Article Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection Lila M. Zarski 1, Patty Sue D. Weber 2, Yao Lee 1 and Gisela Soboll Hussey 1,* 1 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA; [email protected] (L.M.Z.); [email protected] (Y.L.) 2 Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; [email protected] * Correspondence: [email protected] Abstract: Equine herpesvirus 1 (EHV-1) affects horses worldwide and causes respiratory dis- ease, abortions, and equine herpesvirus myeloencephalopathy (EHM). Following infection, a cell- associated viremia is established in the peripheral blood mononuclear cells (PBMCs). This viremia is essential for transport of EHV-1 to secondary infection sites where subsequent immunopathol- ogy results in diseases such as abortion or EHM. Because of the central role of PBMCs in EHV-1 pathogenesis, our goal was to establish a gene expression analysis of host and equine herpesvirus genes during EHV-1 viremia using RNA sequencing. When comparing transcriptomes of PBMCs during peak viremia to those prior to EHV-1 infection, we found 51 differentially expressed equine genes (48 upregulated and 3 downregulated). After gene ontology analysis, processes such as the interferon defense response, response to chemokines, the complement protein activation cascade, cell adhesion, and coagulation were overrepresented during viremia. Additionally, transcripts for EHV-1, EHV-2, and EHV-5 were identified in pre- and post-EHV-1-infection samples. Looking at Citation: Zarski, L.M.; Weber, P.S.D.; micro RNAs (miRNAs), 278 known equine miRNAs and 855 potentially novel equine miRNAs were Lee, Y.; Soboll Hussey, G. -
HS and Product Codes
NATIONAL PARKS BOARD / ANIMAL AND VETERINARY SERVICE (NPARKS/AVS) INDUSTRY AND BIOSECURITY MANAGEMENT GROUP LICENSING AND COMPLIANCE DEPARTMENT LICENSING AND PERMITS SECTION 52 JURONG GATEWAY ROAD, JEM OFFICE TOWER, #09-01 SINGAPORE 608550 HS CODE PRODUCT CODE PRODUCT DESCRIPTION QTY UNIT A) LIVE ANIMALS & BIRDS AND VETERINARY BIOLOGICS AMPHIBIANS (LIVE FROGS) 01069000 VAP0FF LIVE FROGS FOR FISH FEEDING NMB 01069000 VAP0ZZ LIVE FROGS (NON-CITES) NMB 01069000 VAP1ZZ LIVE FROGS (CITES LISTED) NMB BIRDS (CAPTIVE BIRDS) 01063100 VBD1BP BIRDS OF PREY 01063200 VBD1ZZ LIVE BIRDS (CITES LISTED) NMB 01063900 VBD0ZZ LIVE BIRDS (NON-CITES) NMB BREEDING ANIMALS (FOR BREEDING PURPOSE ONLY) 01011000 VBA0HO LIVE HORSES FOR BREEDING NMB LABORATORY ANIMALS (MICE/RATS/GUINEA PIGS/HAMSTERS/RABBITS) 01061900 VLA0GP LIVE GUINEA PIGS NMB 01061900 VLA0HA LIVE HAMSTERS NMB 01061900 VLA0MC LIVE MICE NMB 01061900 VLA0RA LIVE RABBITS NMB 01061900 VLA0RT LIVE RATS NMB 01061900 VLA0ZZ OTHER LABORATORY ANIMALS NMB PET ANIMALS (DOGS/CATS/HORSES/RABBITS/GUINEA PIGS) 01019030 VPA0HO LIVE HORSE FOR RACING NMB 01019030 VPA0PO LIVE PONIES NMB 01061900 VPA0CA LIVE CATS (COMMERCIAL) NMB 01061900 VPA0CP LIVE CATS (PERSONAL) NMB 01061900 VPA0CL LIVE CHINCHILLAS NMB 01061900 VPA0DG LIVE DOGS (COMMERCIAL) NMB 01061900 VPA0DP LIVE DOGS (PERSONAL) NMB 01061900 VPA0GP LIVE GUINEA PIGS NMB 01061900 VPA0HA LIVE HAMSTERS NMB 01061900 VPA0RA LIVE RABBITS NMB 01061900 VPA0ZZ OTHER PET ANIMALS NMB WILD ANIMALS (ZOO ANIMALS) 01061900 VWA0ZZ ZOO ANIMALS (NON-CITES) NMB 01061900 VWA1ZZ ZOO ANIMALS (CITES LISTED) NMB 01061100 VWA1PM PRIMATES NMB 01061200 VWA1DG MANATEES/DUGONGS NMB 01061200 VWA1WD WHALES/DOLPHINS NMB VETERINARY VACCINES 30023000 VVC0ZZ VETERINARY VACCINE - VETERINARY BIOLOGICS 30029000 VVP0B0COWRUMB COWDRIA RUMINANTIUM - 30029000 VVP0B2AERHYDB AEROMONAS HYDROPHILA - 30029000 VVP0B2ANAMARB ANAPLASMA MARGINALE - 30029000 VVP0B2BORBURB BORRELIA BURGDORFERI - 30029000 VVP0B2CAMFETV CAMPYLOBACTER FETUS SUBSP. -
Development of In-House Taqman Qpcr Assay to Detect Equine Herpesvirus-2 in Al-Qadisiyah City ﻟﺛﺎﻧﻲ ا ﻓﺎﯾرو
Iraqi Journal of Veterinary Sciences, Vol. 34, No. 2, 2020 (365-371) Development of in-house Taqman qPCR assay to detect equine herpesvirus-2 in Al-Qadisiyah city M.H. Al-Saadi Department of Internal and Preventive Medicine, College of Veterinary Medicine, University of Al-Qadisiyah, Al-Qadisiyah, Iraq, Email: [email protected] (Received September 6, 2019; Accepted October 1, 2019; Available online July 23, 2020) Abstract EHV-2 is distributed in horses globally. It is clustered within gamma-herpesvirus subfamily and percavirus genus. EHV-2 infection has two phases: latent and lytic. In the later, EHV-2 mainly associated with respiratory and genital symptoms. However, in the quiescent phase of infection, EHV-2 stay dormant in the host till viral reactivation. Our previous study has showed that EHV-2 can be harboured by equine tendons, suggesting that leukocytes possibly carrying EHV-2 for the systemic dissemination. So far, numerous PCR protocols have been performed targeting the gB gene. However, this gene is heterogenic. Therefore, there is a need to develop a quantitative diagnostic approach to detect the quiescent EHV-2 strains. To do this, Taqman qPCR assay was developed to quantify the virus. This was performed by targeting a highly conserved gene known as DNA polymerase (DPOL) gene using constructed plasmid as a standard curve calibrator. The obtained results showed an infection frequency of 33% in which the EHV-2 load reached 6647 copies/100 ng DNA whereas the minimum load revealed as 2 copies/100 ng DNA. The median quantification was found as 141 copies/ 100 ng DNA. -
Shared Ancestry of Herpes Simplex Virus 1 Strain Patton with Recent Clinical Isolates from Asia and with Strain KOS63
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Virology Manuscript Author . Author manuscript; Manuscript Author available in PMC 2018 December 01. Published in final edited form as: Virology. 2017 December ; 512: 124–131. doi:10.1016/j.virol.2017.09.016. Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63 Aldo Pourcheta, Richard Copinb, Matthew C. Mulveyc, Bo Shopsina,b, Ian Mohra, and Angus C. Wilsona,# aDepartment of Microbiology, New York University School of Medicine, New York, New York, USA bDepartment of Medicine, New York University School of Medicine, New York, New York, USA cBeneVir Biopharm, Inc., Gaithersburg, Maryland, USA Abstract Herpes simplex virus 1 (HSV-1) is a widespread pathogen that persists for life, replicating in surface tissues and establishing latency in peripheral ganglia. Increasingly, molecular studies of latency use cultured neuron models developed using recombinant viruses such as HSV-1 GFP- US11, a derivative of strain Patton expressing green fluorescent protein (GFP) fused to the viral US11 protein. Visible fluorescence follows viral DNA replication, providing a real time indicator of productive infection and reactivation. Patton was isolated in Houston, Texas, prior to 1973, and distributed to many laboratories. Although used extensively, the genomic structure and phylogenetic relationship to other strains is poorly known. We report that wild type Patton and the GFP-US11 recombinant contain the full complement of HSV-1 genes and differ within the unique regions at only eight nucleotides, changing only two amino acids. Although isolated in North America, Patton is most closely related to Asian viruses, including KOS63. -
(12) Patent Application Publication (10) Pub. No.: US 2012/0009150 A1 WEBER Et Al
US 2012O009 150A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0009150 A1 WEBER et al. (43) Pub. Date: Jan. 12, 2012 (54) DIARYLUREAS FORTREATINGVIRUS Publication Classification INFECTIONS (51) Int. Cl. (76) Inventors: Olaf WEBER, Wulfrath (DE); st 2. CR Bernd Riedl, Wuppertal (DE) ( .01) A63/675 (2006.01) (21) Appl. No.: 13/236,865 A6II 3/522 (2006.01) A6IP 29/00 (2006.01) (22) Filed: Sep. 20, 2011 A6II 3/662 (2006.01) A638/14 (2006.01) Related U.S. Application Data A63L/7056 (2006.01) A6IP3L/2 (2006.01) (63) Continuation of application No. 12/097.350. filed on A6II 3/44 (2006.01) Nov. 3, 2008, filed as application No. PCTAEPO6/ A6II 3/52 (2006.01) 11693 on Dec. 6, 2006. O O (52) U.S. Cl. .......... 424/85.6; 514/350; 514/171; 514/81; (30) Foreign Application Priority Data 514/263.38: 514/263.4: 514/120: 514/4.3: Dec. 15, 2005 (EP) .................................. 05O274513 424/85.7; 514/43 Dec. 15, 2005 (EP). ... O5O27452.1 Dec. 15, 2005 (EP). ... O5O27456.2 Dec. 15, 2005 (EP). ... O5O27458.8 The present invention relates to pharmaceutical compositions Dec. 15, 2005 (EP) O5O27.460.4 for treating virus infections and/or diseases caused by virus Dec. 15, 2005 (EP) O5O27462.O infections comprising at least a diary1 urea compound option Dec. 15, 2005 (EP). ... O5O27465.3 ally combined with at least one additional therapeutic agent. Dec. 15, 2005 (EP). ... O5O274.67.9 Useful combinations include e.g. BAY 43-9006 as a diaryl Dec. -
Supplementary Material
SUPPLEMENTARY MATERIAL Appendix; Search strategy MEDLINE 1. Herpes Labialis/ 2. Stomatitis, Herpetic/ 3. ((herpe* adj3 (labial* or stomatiti* or gingivostomatiti*)) or cold-sore* or fever-blister*).tw,kf. 4. 1 or 2 or 3 5. Herpes Simplex/ 6. Simplexvirus/ or herpesvirus 1, human/ or herpesvirus 2, human/ 7. (hsv-1 or hsv1 or hsv-2 or hsv2 or simplexvirus or simplex-virus or herpes-simplex or herpe*).tw,kf. 8. exp Mouth/ 9. (lip*1 or mouth or labial* or orolabial* or oro-labial* or perioral or peri-oral or extraoral or extra-oral or intraoral or intra-oral or gingiva* or gingivo*).tw,kf. 10. (5 or 6 or 7) and (8 or 9) 11. 4 or 10 12. Secondary Prevention/ 13. exp Recurrence/ 14. (prevention or recurren* or prophyla*).tw,kf. 15. pc.fs. 16. 12 or 13 or 14 or 15 17. 11 and 16 18. exp animals/ not human*.sh. 19. 17 not 18 EMBASE 1. herpes labialis/ 2. herpetic stomatitis/ 3. ((herpe* adj3 (labial* or stomatiti* or gingivostomatiti*)) or cold-sore* or fever-blister*).tw,kw,dq. 4. 1 or 2 or 3 5. herpes simplex/ 6. simplexvirus/ or exp human alphaherpesvirus 1/ or exp herpes simplex virus 2/ 7. (hsv-1 or hsv1 or hsv-2 or hsv2 or simplexvirus or simplex-virus or herpes-simplex or herpe*).tw,kw,dq. 8. mouth/ or exp cheek/ or exp lip/ or exp mouth cavity/ or exp mouth floor/ or exp mouth mucosa/ or exp palate/ or oral blister/ 9. (lip*1 or mouth or labial* or orolabial* or oro-labial* or perioral or peri-oral or extraoral or extra-oral or intraoral or intra-oral or gingiva* or gingivo*).tw,kw,dq. -
"Fischgesundheit Und Fischerei Im Wandel Der Zeit"
Fischgesundheit und Fischerei im Wandel der Zeit Tagungsband XV. Gemeinschaftstagung der Deutschen, Österreichischen und Schweizer Sektionen der European Association of Fish Pathologists (EAFP) Starnberg, 8. – 10. Oktober 2014 Die Tagung wurde in wesentlichen Teilen finanziert vom Bayerischen Staatsministerium für Ernährung, Landwirtschaft und Forsten (StMELF) aus der Fischereiabgabe Bayerns Weitere Unterstützung erfolgte durch: ― Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit ― Bayerische Landesanstalt für Landwirtschaft, Institut für Fischerei ― MSD Tiergesundheit, Intervet Deutschland GmbH ― Zentralverband Zoologischer Fachbetriebe (ZZF) und Wirtschaftsgemeinschaft Zoolo- gischer Fachbetriebe GmbH (WZF) ― Familie Gerda und Hartmut Stachowitz ― Oswald Fürneisen ― Tetra GmbH, Melle ― BioMar Group Für die Erstellung des Tagungsbandes wurden die von den Autoren eingesandten Manu- skripte bzw. Zusammenfassungen verwendet. Für die Inhalte und Abbildungen sind die Autoren verantwortlich. Einige Beiträge wurden oder werden an anderer Stelle veröffent- licht. Im vorliegenden Tagungsband sind Zusammenfassungen dieser Beiträge veröffent- licht. Zitiervorschlag KLEINGELD, D. W., und WEDEKIND, H. (Hrsg.) (2015): Fischgesundheit und Fische- rei im Wandel der Zeit. XV. Gemeinschaftstagung der Deutschen, Österreichischen und Schweizer Sektion der European Association of Fish Pathologists (EAFP), 8. – 10. Okto- ber 2014 an der LfL in Starnberg. Impressum Herausgeber: Bayerische Landesanstalt für Landwirtschaft, Vöttinger -
Comparison of the Gene Coding Contents and Other Unusual Features of the GC-Rich and AT-Rich Branch Probosciviruses
RESEARCH ARTICLE Ecological and Evolutionary Science crossmark Comparison of the Gene Coding Contents and Other Unusual Features of the GC-Rich and AT-Rich Branch Probosciviruses Paul D. Ling,a Simon Y. Long,b Jian-Chao Zong,b Sarah Y. Heaggans,b Xiang Qin,c Gary S. Haywardb Baylor College of Medicine, Houston, Texas, USAa; Viral Oncology Program, The Johns Hopkins School of Medicine, Baltimore, Maryland, USAb; The Human Genome Sequencing Center, Houston, Texas, USAc ABSTRACT Nearly 100 cases of lethal acute hemorrhagic disease in young Asian elephants have been reported worldwide. All tested cases contained high levels of Received 13 April 2016 Accepted 9 May elephant endotheliotropic herpesvirus (EEHV) DNA in pathological blood or tissue 2016 Published 15 June 2016 Citation Ling PD, Long SY, Zong J-C, Heaggans samples. Seven known major types of EEHVs have been partially characterized and SY, Qin X, Hayward GS. 2016. Comparison of shown to all belong to the novel Proboscivirus genus. However, the recently deter- the gene coding contents and other unusual mined 206-kb EEHV4 genome proved to represent the prototype of a GC-rich features of the GC-rich and AT-rich branch probosciviruses. mSphere 1(3):e00091-16. branch virus that is very distinct from the previously published 180-kb EEHV1A, doi:10.1128/mSphere.00091-16. EEHV1B, and EEHV5A genomes, which all fall within an alternative AT-rich branch. Editor Blossom Damania, UNC-Chapel Hill Although EEHV4 retains the large family of 7xTM and vGPCR-like genes, six are Copyright © 2016 Ling et al. This is an open- unique to either just one or the other branch. -
From the Hallowed Halls of Herpesvirology: a Tribute To
b1227_FM.qxd 2/15/2012 10:12 AM Page vii b1227 From the Hallowed Halls of Herpesvirology CONTENTS Preface xi Chapter 1 The HSV-2 Gene ICP10PK: A Future in the 1 Therapy of Neurodegeneration Laure Aurelian Chapter 2 What Doesn’t Belong and Why: a Saga of 23 Latency Associated Proteins Elaborated by Varicella Zoster Virus Matthew S. Walters, Christos A. Kyratsous, Christina L. Stallings, Octavian Lungu and Saul J. Silverstein Chapter 3 Selected Aspects of Herpesvirus DNA Replication, 59 Cleavage/Packaging and the Development and Use of Viral Amplicon Vectors Niza Frenkel, Ronen Borenstein and Haim Zeigerman Chapter 4 Chromatin Structure of the Herpes Simplex Virus 1 93 Genome During Lytic and Latent Infection Anna R. Cliffe and David M. Knipe Chapter 5 The Proboscivirus Genus: Hemorrhagic Disease 123 Caused by Elephant Endotheliotropic Herpesviruses Jian-Chao Zong, Erin Latimer, Sarah Y. Heaggans, Laura K. Richman and Gary S. Hayward vii b1227_FM.qxd 2/15/2012 10:12 AM Page viii b1227 From the Hallowed Halls of Herpesvirology viii Contents Chapter 6 A Molecular Mass Gradient is the Key Parameter 155 of the Genetic Code Organization Felix Filatov Chapter 7 From Latent Herpes Viruses to Persistent Bornavirus 169 Dedicated to Bernard Roizman Hanns Ludwig and Liv Bode Chapter 8 Virus Infections and Development 187 of Cervical Cancer Bodil Norrild Chapter 9 Cytomegalovirus Control of Cell Death Pathways 201 A. Louise McCormick and Edward S. Mocarski Chapter 10 Herpesviruses as Oncolytic Agents 223 Gabriella Campadelli-Fiume, Laura Menotti, Grace Zhou, Carla De Giovanni, Patrizia Nanni and Pier Luigi Lollini Chapter 11 Role of Cellular MicroRNAs During Human 251 Cytomegalovirus Infection Kavitha Dhuruvasan, Geetha Sivasubramanian and Philip E. -
A Scoping Review of Viral Diseases in African Ungulates
veterinary sciences Review A Scoping Review of Viral Diseases in African Ungulates Hendrik Swanepoel 1,2, Jan Crafford 1 and Melvyn Quan 1,* 1 Vectors and Vector-Borne Diseases Research Programme, Department of Veterinary Tropical Disease, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa; [email protected] (H.S.); [email protected] (J.C.) 2 Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium * Correspondence: [email protected]; Tel.: +27-12-529-8142 Abstract: (1) Background: Viral diseases are important as they can cause significant clinical disease in both wild and domestic animals, as well as in humans. They also make up a large proportion of emerging infectious diseases. (2) Methods: A scoping review of peer-reviewed publications was performed and based on the guidelines set out in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews. (3) Results: The final set of publications consisted of 145 publications. Thirty-two viruses were identified in the publications and 50 African ungulates were reported/diagnosed with viral infections. Eighteen countries had viruses diagnosed in wild ungulates reported in the literature. (4) Conclusions: A comprehensive review identified several areas where little information was available and recommendations were made. It is recommended that governments and research institutions offer more funding to investigate and report viral diseases of greater clinical and zoonotic significance. A further recommendation is for appropriate One Health approaches to be adopted for investigating, controlling, managing and preventing diseases. Diseases which may threaten the conservation of certain wildlife species also require focused attention. -
Shedding of the Salmonid Herpesvirus-3 by Infected Lake Trout (Salvelinus Namaycush)
viruses Communication Shedding of the Salmonid Herpesvirus-3 by Infected Lake Trout (Salvelinus namaycush) Mohamed Faisal 1,2,3, Mochamad Purbayu 3, Megan A. Shavalier 2,3, Terence L. Marsh 4 and Thomas P. Loch 1,2,* 1 Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA 2 Department of Fisheries and Wildlife, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824, USA 3 Comparative Medicine and Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA 4 Department of Microbiology and Molecular Genetics, College of Natural Science, Michigan State University, East Lansing, MI 48824, USA * Correspondence: [email protected]; Tel.: +517-884-2019; Fax: +517-432-2310 Received: 9 May 2019; Accepted: 20 June 2019; Published: 26 June 2019 Abstract: Salmonid Herpesvirus-3, commonly known as the Epizootic Epitheliotropic Disease virus (EEDV), causes a disease of lake trout (Salvelinus namaycush) that has killed millions of fish over the past several decades. Currently, most aspects of EEDV disease ecology remain unknown. In this study, we investigated EEDV shedding in experimentally challenged (intracoelomic injection) lake trout that were individually microchipped. In order to assess viral shedding, each infected fish was placed in individual static, aerated aquaria for a period of 8 h, after which the water was assessed for the presence of EEDV DNA using quantitative PCR. Water sampling was conducted every seven days for 93 days post-infection (pi), followed by additional sampling after one year. Results demonstrated that lake trout began shedding EEDV into the water as early as 9 days pi.